Partnership
Strategic Partnerships for Autophagy Activator Development
We have developed novel small-molecule lead compounds that enhance autophagy activity, aiming to create innovative medicines.
MORESCO Corporation, a chemical manufacturing company based in Kobe, Japan, has recently focused on drug discovery targeting autophagy activators in collaboration with Professor Tamotsu Yoshimori of Osaka University and AutoPhagyGO Inc., a start-up company dedicated to the practical application of autophagy research.
Autophagy is widely recognized for its essential roles in cell survival and maintenance. Dysfunction in autophagy is considered to cause numerous human diseases. We have developed novel small-molecule lead compounds that enhance autophagy activity by monitoring autophagy assay (tfLC3 assay) in HeLa cells. To further develop our autophagy activators, we are seeking business partners for collaboration and out-licensing opportunities.
Business Domain / 分野
Business Type / 業種
Disease Area / 疾患領域
Modalities / モダリティ
Technologies / 技術
Additional questions
Researched company/organisation type / マッチングご希望企業・機関のタイプ
Researched disease area / マッチングご希望の疾患領域
Researched Modality / マッチングご希望のモダリティ
Researched Technologies / マッチングご希望の技術
Partnership
Strategic Partnerships for Autophagy Activator Development
We have developed novel small-molecule lead compounds that enhance autophagy activity, aiming to create innovative medicines.